A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer’s disease

By sjmartinez • September 6, 2024

Sakimura K, Kawai T, Nashida R, Ishida Y, Harada K, Suzuki T, Okuma C, Cole GM. A novel PDHK inhibitor restored cognitive dysfunction and limited neurodegeneration without affecting amyloid pathology in 5xFAD mouse, a model of Alzheimer's disease. Alzheimers Res Ther. 2024 Sep 5;16(1):197. doi: 10.1186/s13195-024-01552-2. PMID: 39238036.

Tags: 5xFAD, Aerobic glycolysis, Alzheimer’s disease, Geriatrics, Glucose metabolism, GRECC, PDH, PDHK, Publications, Pyruvate dehydrogenase, Pyruvate dehydrogenase kinase, Veterans Administration

Related Posts

A multisite feasibility study of integrated cognitive-behavioral treatment for co-existing nocturia and chronic insomnia

Fung CH, Huang AJ, Markland AD, Schembri M, Martin JL, Bliwise DL, Cheng J, Alessi CA, Johnson TM 2nd, Burgio KL, Muirhead L, Neymark A,[...]

Masked Taper With Behavioral Intervention for Discontinuation of Benzodiazepine Receptor Agonists: A Randomized Clinical Trial

Fung CH, Alessi C, Martin JL, Josephson K, Kierlin L, Dzierzewski JM, Moore AA, Badr MS, Zeidler M, Kelly M, Smith JP, Cook IA, Der-Mcleod[...]

The association between BMI and cognition in India: data from the Longitudinal Aging Study in India (LASI)

Nichols E, Gross AL, Hu P, Sekher TV, Dey AB, Lee J. The association between BMI and cognition in India: data from the Longitudinal Aging[...]